Valuation Ind-Swift Laboratories Limited Bombay S.E.

Stocks

Delayed Bombay S.E. Other stock markets 03:36:41 2026-06-19 EDT			5-day change	1st Jan Change
176.50 ^INR	+4.75%		+8.35%	+100.14%

05-28	Ind-Swift Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026	CI
04-07	Ind Swift Laboratories says tribunal rejected all claims of PI Industries, counterclaims of co, others	RE

Data adjusted to current consolidation scope

Fiscal Period: March	2020	2021	2022	2023	2024	2025
Market Cap ¹	1,202	4,251	3,938	3,262	5,918	4,961
Change	-	253.56%	-7.37%	-17.18%	81.43%	-16.17%
Enterprise Value (EV) ¹	11,410	14,189	13,254	11,701	1,764	695.5
Change	-	24.36%	-6.59%	-11.72%	-84.92%	-60.59%
P/E	-4.75x	-135x	-183x	6.85x	1.41x	2.38x
PBR	0.19x	0.7x	0.66x	0.48x	0.64x	0.49x
PEG	-	1.5x	5.8x	-0x	0x	-0x
Capitalization / Revenue	0.15x	0.47x	0.37x	0.27x	0.46x	0.88x
EV / Revenue	1.43x	1.56x	1.26x	0.96x	0.14x	0.12x
EV / EBITDA	8.88x	8.54x	5.96x	4.9x	0.66x	-3.19x
EV / EBIT	15.4x	12.8x	14.3x	6.45x	0.82x	-1.59x
EV / FCF	46.6x	58x	49.3x	26.6x	0.18x	-0.33x
FCF Yield	2.15%	1.72%	2.03%	3.76%	558%	-302%
Dividend per Share ²	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-
EPS ²	-4.284	-0.5326	-0.3637	8.055	71.24	35.21
Distribution rate	-	-	-	-	-	-
Net sales ¹	7,993	9,068	10,521	12,159	12,973	5,617
EBITDA ¹	1,285	1,661	2,224	2,389	2,683	-217.8
EBIT ¹	739.6	1,110	924.1	1,815	2,150	-438.6
Net income ¹	-211.9	-31.47	-21.49	476	4,210	2,505
Net Debt ¹	10,207	9,938	9,315	8,439	-4,153	-4,265
Reference price ²	20.35	71.95	66.65	55.20	100.15	83.96
Nbr of stocks (in thousands)	59,087	59,087	59,087	59,087	59,087	59,087
Announcement Date	9/7/20	9/7/21	9/7/22	9/5/23	9/6/24	9/5/25

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	37.64x	7.13x	24.31x	0.82%	46.46B
OTSUKA HOLDINGS CO., LTD.	18x	2.02x	9.57x	1.34%	35.42B
CIPLA LIMITED	26.16x	3.21x	16.43x	0.92%	11.62B
ZYDUS LIFESCIENCES LIMITED	23.56x	4.11x	15.32x	0.75%	11.47B
KRKA, D. D.	19.71x	3.4x	12.36x	3.46%	9.13B
GEDEON RICHTER	8.16x	1.91x	5x	5.31%	6.94B
ONO PHARMACEUTICAL CO., LTD.	15.01x	1.97x	7.47x	3.57%	6.65B
GLENMARK PHARMACEUTICALS LIMITED	32.7x	3.71x	15.8x	0.24%	6.45B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	40.51x	-	-	-	5.01B
Average	24.61x	3.43x	13.28x	2.05%	15.46B
Weighted average by Cap.	26.67x	4.24x	15.91x	1.48%